Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.
Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.
Virology. 2019 Aug;534:14-24. doi: 10.1016/j.virol.2019.05.016. Epub 2019 May 28.
Chikungunya virus (CHIKV) is an important arthritogenic human pathogen that is already circulating in both hemispheres. In the present study, we substituted VLoop, located on the surface of nsP2, by other amino acid sequences. These modifications had deleterious effects on viral nuclear functions and made CHIKV incapable of interfering with the induction of type I interferon and the antiviral response in both mouse and human cells. Importantly, the identified mutations have no significant effects on the synthesis of virus-specific RNAs and viral structural proteins. The designed mutants induced a few orders of magnitude lower viremia but remained highly immunogenic in mice. Thus, the proposed modifications of nsP2 can additionally improve the safety of the attenuated strain CHIKV 181/25. Furthermore, defined mutations in the macro domain of another nonstructural protein, nsP3, additionally reduce cytopathogenicity of nsP2 mutants in human cells, and can be potentially applied for CHIKV attenuation.
基孔肯雅病毒(CHIKV)是一种重要的致关节炎人类病原体,已经在两个半球传播。在本研究中,我们用其他氨基酸序列替代了位于 nsP2 表面的 VLoop。这些修饰对病毒的核功能有有害影响,使 CHIKV 无法干扰 I 型干扰素的诱导和小鼠和人细胞中的抗病毒反应。重要的是,鉴定的突变对病毒特异性 RNA 和病毒结构蛋白的合成没有显著影响。设计的突变体引起的病毒血症低几个数量级,但在小鼠中仍具有高度免疫原性。因此,nsP2 的提议修饰可进一步提高减毒菌株 CHIKV 181/25 的安全性。此外,另一种非结构蛋白 nsP3 的宏结构域中的定义突变进一步降低了 nsP2 突变体在人细胞中的细胞病变性,并且可潜在地用于 CHIKV 减毒。